Oct 20 |
With 72% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
|
Oct 17 |
AstraZeneca (AZN): High-Growth UK Stock with Strong Pipeline
|
Oct 17 |
The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries
|
Oct 17 |
The best stocks to buy in the UK, according to Barclays
|
Oct 16 |
Top Research Reports for AstraZeneca, Accenture & AT&T
|
Oct 15 |
J&J Beats on Q3 Earnings, Raises Sales View but Cuts EPS Guidance
|
Oct 15 |
RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
|
Oct 14 |
AZN or NVO: Which Is the Better Value Stock Right Now?
|
Oct 14 |
ENHERTU gains conditional approval in China to treat NSCLC
|
Oct 14 |
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
|